Cobenfy is the first drug to treat the disease that targets the brain's cholinergic receptors


Washington: The US Food and Drug Administration has approved a new drug for adults with schizophrenia.
The drug, commonly known as Cobenfy, is the first drug to treat the disease that targets the brain's cholinergic receptors, rather than the dopamine receptors that are the traditional focus of treatment.
“Schizophrenia is the leading cause of disability worldwide,” said Dr. Tiffany Farshion in the Institute's Department of Neuroscience.
He stated the drug represents the first new approach to treating schizophrenia. It offers a new alternative to the antipsychotic drugs that have previously been prescribed to people with schizophrenia.
It is pertinent to note that schizophrenia is a severe, chronic mental illness that often impairs a person's quality of life.
Pakistan, Romania agree to address aerial defence challenges
- 8 hours ago

Gold prices fall thousands in value in Pakistan
- 12 hours ago
.jpeg&w=3840&q=75)
Pakistan acts as a global shield against terrorism
- 11 hours ago

Bulls' White (calf) to miss at least 2 more weeks
- a day ago

5.3 magnitude earthquake rocks Islamabad, parts of KP and Punjab
- a day ago

Why many transgender Americans are preparing to flee the country
- 21 hours ago
PNS Yarmook seizes narcotics worth $972m
- 13 hours ago

Most animals on this island nation are found nowhere else on Earth. And now they’re vanishing.
- 21 hours ago
18th Chief of the Naval Staff Amateur Golf Cup 2025 commences in Islamabad
- 11 hours ago
Pakistan consolidating macroeconomic stability, aims 3.5pc growth despite floods: FinMin
- 12 hours ago
Six terrorists of Fitna al-Hindustan neutralised in Balochistan's Dalbandin
- 8 hours ago

There should be no war with Pakistan, issues can be resolved through trade, Trump tells Modi
- 16 hours ago